Full Business Value: sarepta.com (SRPT)

Graphic logo of Sarepta Corp (SRPT)

Sarepta Therapeutics, Inc. (SRPT) specializes in developing advanced RNA-based therapies to combat Duchenne muscular dystrophy. This current share price chart, where the Enterprise Value stands at 2224.14, reflects the dynamics of a business that remains resilient to macroeconomic fluctuations due to insurance reimbursements. High demand for unique genome editing methods and an expanding portfolio of approved drugs ensure steady growth of the customer base.

Sarepta Corp - SRPT Enterprise Value (period 11/23/2025 - 11/01/2026)

Sarepta Therapeutics, Inc. (SRPT) - metric breakdowns and financial figures

- stock quotes and analyst forecast:
Price Performance Chart Sarepta Therapeutics|SRPT - Price Target Chart
- company stock exchange capitalization indicators:
Market Valuation Sarepta|SRPT - Real Price to Acquire Entire Company
- book capitalization indicators:
Book Price of a Share Sarepta|SRPT - Book Capitalization|Capitalization to Book Value Ratio sarepta.com|SRPT - Aggregate Company Assets
- company total debt and liquidity indicators:
Debt to Equity Ratio Sarepta Therapeutics, Inc.|SRPT - Long-Term Debt to Capital|Short-Term Debt to Capital sarepta.com|SRPT - Company Debts|Debts to Net Assets Sarepta|SRPT - Company Long-Term Debts|Company Short-Term Debts Sarepta|Intermediate Coverage Ratio sarepta.com
- financial results and valuation multiples details:
SRPT - Net Profit
Analysis of all company metrics:SRPT Sarepta Therapeutics
Flagship merchandise of Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc. (SRPT) is scaling high-margin gene therapy sales by leveraging patent protection. Enterprise Value combines market capitalization with net debt, excluding cash and cash equivalents. This metric determines the actual investment required for a full buyout of the business. It reveals hidden debt burdens that may distort the external attractiveness of the shares. Analyzing historical EV levels helps assess the effectiveness of the company's balance sheet management.

Who Sarepta Therapeutics, Inc. competes with

Value Adjusted for Debt and Cash TEM|QGEN - Total Company Value|Full Business Value IONS|RGEN (Repligen Corporation) - Real Price to Acquire Entire Company|RNA: Aggregate Business Value|CRSP (CRISPR Therapeutics) - Enterprise Value|Business Value WGS (GeneDx Holdings)|Total Company Value Ultragenyx Pharma (RARE)|Beam Tx - Business Value|Enterprise Value TWST (Twist Bioscience)|Enterprise Value 10xgenomics.com TXG|NTLA - Total Company Value|Company Buyout Price Stoke Therapeutics Inc STOK|BLFS: Enterprise Value|Wave Pharma (WVE) - Enterprise Value|Total Company Value Maze Therapeutics Inc|SION: Value Adjusted for Debt and Cash|Enterprise Value PRME|TSHA - Total Enterprise Value|Total Company Value uniQure Corp QURE|MGTX (MeiraGTx Corp) - Full Business Value|RGNX: Real Price to Acquire Entire Company|solidbio.com - Aggregate Business Value|OCGN: Enterprise Value|Pacific Biosciences of California, Inc. (PACB) - Enterprise Value|Real Price to Acquire Entire Company BNTC|DSGN: Value Adjusted for Debt and Cash|Real Price to Acquire Entire Company RCKT (Rocket Pharmaceuticals)|Aggregate Business Value FDMT|Enterprise Value LXEO (Lexeo Therapeutics, Inc.)|Value Adjusted for Debt and Cash KRRO|Editas - Enterprise Value|Total Enterprise Value Silence Therapeutics Corp|proqr.com (PRQR) - Total Company Value|Codexis - Value Adjusted for Debt and Cash|SGMO (Sangamo Therapeutics, Inc.) - Enterprise Value|Enterprise Value Nautilus Biotechnology Inc|Total Company Value Metagenomi, Inc (MGX)|DTIL: Full Business Value|Enterprise Value GBIO (Generation Bio)|boundlessbio.com (BOLD) - Total Enterprise Value|XCUR: Real Price to Acquire Entire Company|IMNN - Enterprise Value|PHIO (phiopharma.com) - Real Price to Acquire Entire Company|MBIO: Aggregate Business Value|RNAZ (TransCode Therapeutics Inc.) - Enterprise Value|Bionano (BNGO) - Company Buyout Price|Enterprise Value APDN|Real Price to Acquire Entire Company bluebird bio Inc. BLUE|Total Company Value ImmunoPrecise Antibodies Ltd. IPA|Company Buyout Price Omega Therapeutics Corp (OMGA)|OMIC: Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash RGLS (regulusrx.com)|SYRS: Enterprise Value|TBIO - Company Buyout Price|Total Company Value TRACON|Business Value UBX (Unity Biotechnology, Inc)